Studies related to Lung Function and N-Acetylcysteine

Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease
Effect None
Trial Design doubleblind
Trial Length 1week
Number of Subjects 50
Sex mixed
Notes for this study:
Supplementation of 600mg NAC in persons undergoing exacerbations of COPD symptoms failed to improve any measured symptom or lung function more than placebo.